States and Origins of Mammalian Embryonic Pluripotency In Vivo and in a Dish

Current Topics in Developmental Biology
Priscila Ramos-IbeasR Alberio

Abstract

Mouse embryonic stem cells (ESC), derived from preimplantation embryos in 1981, defined mammalian pluripotency for many decades. However, after the derivation of human ESC in 1998, comparative studies showed that different types of pluripotency exist in early embryos and that these can be captured in vitro under various culture conditions. Over the past decade much has been learned about the key signaling pathways, growth factor requirements, and transcription factor profiles of pluripotent cells in embryos, allowing improvement of derivation and culture conditions for novel pluripotent stem cell types. More recently, studies using single-cell transcriptomics of embryos from different species provided an unprecedented level of resolution of cellular interactions and cell fate decisions that are informing new ways to understand the emergence of pluripotency in different organisms. These new approaches enhance knowledge of species differences during early embryogenesis and will be instrumental for improving methodologies for generating intra- and interspecies chimeric animals using pluripotent stem cells. Here, we discuss the recent developments in our understanding of early embryogenesis in different mammalian species.

Citations

Jul 6, 2019·BMC Developmental Biology·Jesica R CanizoRamiro Alberio
Apr 24, 2021·Zygote : the Biology of Gametes and Early Embryos·Tong YuYunhai Zhang
Jul 3, 2021·Frontiers in Veterinary Science·Alba Pérez-GómezPriscila Ramos-Ibeas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

© 2022 Meta ULC. All rights reserved